DNAX accessory molecule-1 (CD226) promotes human hepatocellular carcinoma cell lysis by Vγ9Vδ2 T cells

European Journal of Immunology

Volumn 39, Issue 5, 2009, Pages 1361-1368

  Toutirais, Olivier ^a   Cabillic, Florian ^a,b   Le Friec, Gaëlle ^c   Salot, Samuel ^d   Loyer, Pascal ^a   Le Gallo, Matthieu ^a   Desille, Mireille ^a   de La Pintière, Cécile Thomas ^b   Daniel, Pascale ^b   Bouet, Françoise ^a,b   Catros, Véronique ^a,b  

^a UNIVERSITÉ DE RENNES 1   (France)

^b RENNES UNIVERSITY HOSPITAL   (France)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d INNATE PHARMA   (France)

Author keywords

T cells; Antitumor immunotherapy; Innate immunity; Nectins; NK receptors

Indexed keywords

DNAX ACCESSORY MOLECULE 1 PROTEIN; GAMMA INTERFERON; LYMPHOCYTE ANTIGEN; MONOCLONAL ANTIBODY; NATURAL KILLER CELL RECEPTOR; NATURAL KILLER CELL RECEPTOR CD96; NATURAL KILLER CELL RECEPTOR NKG2D; NECTIN 2; NECTIN LIKE 5 PROTEIN; UNCLASSIFIED DRUG; CD226 ANTIGEN; CD96 ANTIGEN; CELL ADHESION MOLECULE; LEUKOCYTE ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; NECTINS; POLIOVIRUS RECEPTOR; SMALL INTERFERING RNA; T LYMPHOCYTE ANTIGEN; VIRUS RECEPTOR;

ARTICLE; CANCER CELL CULTURE; CANCER IMMUNOTHERAPY; CELL FUNCTION; CELL KILLING; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOLYSIS; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; BIOSYNTHESIS; CYTOTOXICITY; FLOW CYTOMETRY; GENETIC TRANSFECTION; GENETICS; IMMUNOLOGY; IMMUNOTHERAPY; INNATE IMMUNITY; LIVER TUMOR; LYMPHOCYTE ACTIVATION; METHODOLOGY; TUMOR CELL LINE;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CARCINOMA, HEPATOCELLULAR; CELL ADHESION MOLECULES; CELL LINE, TUMOR; CYTOTOXICITY, IMMUNOLOGIC; FLOW CYTOMETRY; HUMANS; IMMUNITY, INNATE; IMMUNOTHERAPY; LIVER NEOPLASMS; LYMPHOCYTE ACTIVATION; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; RECEPTORS, VIRUS; RNA, SMALL INTERFERING; T-LYMPHOCYTES; TRANSFECTION;

EID: 67649966533     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200838409     Document Type: Article

References (30)

1. Greten, T. F., Manns, M. P. and Korangy, F., Immunotherapy of hepatocellular carcinoma. J Hepatol. 2006. 45: 868-878.
2. Kabelitz, D., Wesch, D. and He, W., Perspectives of gammadelta T cells in tumor immunology. Cancer Res. 2007. 67: 5-8.
3. Corvaisier, M., Moreau-Aubry, A., Diez, E., Bennouna, J., Mosnier, J. F., Scotet, E., Bonneville, M. et al., V gamma 9V delta 2 T cell response to colon carcinoma cells. J. Immunol. 2005. 175: 5481-5488.
4. Viey, E., Fromont, G., Escudier, B., Morel, Y., Da Rocha, S., Chouaib, S. and Caignard, A., Phosphostim-activated gamma delta T cells kill autologous metastatic renal cell carcinoma. J. Immunol. 2005. 174: 1338-1347.
5. Bouet-Toussaint, F., Cabillic, F., Toutirais, O., Le Gallo, M., Thomas de la Pintiere, C., Daniel, P., Genetet, N. et al., Vgamma9Vdelta2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomas. Cancer Immunol. Immunother. 2008. 57: 531-539.
6. Mattarollo, S. R., Kenna, T., Nieda, M. and Nicol, A. J., Chemotherapy and zoledronate sensitize solid tumour cells to Vgamma9Vdelta2 T cell cytotoxicity. Cancer Immunol. Immunother. 2007. 56: 1285-1297.
7. Thomas, M. L., Samant, U. C., Deshpande, R. K. and Chiplunkar, S. V., Gammadelta T cells lyse autologous and allogenic oesophageal tumours: Involvement of heat-shock proteins in the tumour cell lysis. Cancer Immunol. Immunother. 2000. 48: 653-659.
8. Sato, K., Kimura, S., Segawa, H., Yokota, A., Matsumoto, S., Kuroda, J., Nogawa, M. et al., Cytotoxic effects of gammadelta T cells expanded ex vivo by a third generation bisphosphonate for cancer immunotherapy. Int. J. Cancer 2005. 116: 94-99.
9. von Lilienfeld-Toal, M., Nattermann, J., Feldmann, G., Sievers, E., Frank, S., Strehl, J. and Schmidt-Wolf, I. G., Activated gammadelta T cells express the natural cytotoxicity receptor natural killer p 44 and show cytotoxic activity against myeloma cells. Clin. Exp. Immunol. 2006. 144: 528-533.
10. Kenna, T., Golden-Mason, L., Norris, S., Hegarty, J. E., O'Farrelly, C. and Doherty, D. G., Distinct subpopulations of gamma delta T cells are present in normal and tumor-bearing human liver. Clin. Immunol. 2004. 113: 56-63.
11. Gober, H. J., Kistowska, M., Angman, L., Jeno, P., Mori, L. and De Libero, G., Human T cell receptor gamma delta cells recognize endogenous mevalonate metabolites in tumor cells. J. Exp. Med. 2003. 197: 163-168.
12. Scotet, E., Martinez, L. O., Grant, E., Barbaras, R., Jeno, P., Guiraud, M., Monsarrat, B. et al., Tumor recognition following Vgamma9Vdelta2 T cell receptor interactions with a surface F1-ATPase-related structure and apolipoprotein A-I. Immunity 2005. 22: 71-80.
13. Vantourout, P., Martinez, L. O., Fabre, A., Collet, X. and Champagne, E., Ecto-F1-ATPase and MHC-class I close association on cell membranes. Mol. Immunol. 2008. 45: 485-492.
14. Bukowski, J. F., Morita, C. T., Tanaka, Y., Bloom, B. R., Brenner, M. B. and Band, H., V gamma 2V delta 2 TCR-dependent recognition of non-peptide antigens and Daudi cells analyzed by TCR gene transfer. J. Immunol. 1995. 154: 998-1006.
15. Groh, V., Rhinehart, R., Secrist, H., Bauer, S., Grabstein, K. H. and Spies, T., Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB. Proc. Natl. Acad. Sci. USA 1999. 96: 6879-6884.
16. Fuchs, A. and Colonna, M., The role of NK cell recognition of nectin and nectin-like proteins in tumor immunosurveillance. Semin. Cancer Biol. 2006. 16: 359-366.
17. Sakisaka, T., Ikeda, W., Ogita, H., Fujita, N. and Takai, Y., The roles of nectins in cell adhesions: Cooperation with other cell adhesion molecules and growth factor receptors. Curr. Opin. Cell Biol. 2007. 19: 593-602.
18. Bottino, C., Castriconi, R., Pende, D., Rivera, P., Nanni, M., Carnemolla, B., Cantoni, C. et al., Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule. J. Exp. Med. 2003. 198: 557-567.
19. Tahara-Hanaoka, S., Shibuya, K., Onoda, Y., Zhang, H., Yamazaki, S., Miyamoto, A., Honda, S. et al., Functional characterization of DNAM-1 (CD226) interaction with its ligands PVR (CD155) and nectin-2 (PRR-2/CD112). Int. Immunol. 2004. 16: 533-538.
20. Fuchs, A., Cella, M., Giurisato, E., Shaw, A. S. and Colonna, M., Cutting edge: CD96 (tactile) promotes NK cell-target cell adhesion by interacting with the poliovirus receptor (CD155). J. Immunol. 2004. 172: 3994-3998.
21. Tanaka, Y., Human gamma delta T cells and tumor immunotherapy. J. Clin. Exp. Hematop. 2006. 46: 11-23.
22. Shibuya, K., Lanier, L. L., Phillips, J. H., Ochs, H. D., Shimizu, K., Nakayama, E., Nakauchi, H. et al., Physical and functional association of LFA-1 with DNAM-1 adhesion molecule. Immunity 1999. 11: 615-623.
23. Shibuya, A., Campbell, D., Hannum, C., Yssel, H., Franz-Bacon, K., McClanahan, T., Kitamura, T. et al., DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes. Immunity 1996. 4: 573-581.
24. Ralston, K. J., Hird, S. L., Zhang, X., Scott, J. L., Jin, B., Thorne, R. F., Berndt, M. C. et al., The LFA-1-associated molecule PTA-1 (CD226) on T cells forms a dynamic molecular complex with protein 4.1G and human discs large. J. Biol. Chem. 2004. 279: 33816-33828.
25. Shibuya, A., Lanier, L. L. and Phillips, J. H., Protein kinase C is involved in the regulation of both signaling and adhesion mediated by DNAX accessory molecule-1 receptor. J. Immunol. 1998. 161: 1671-1676.
26. Pende, D., Bottino, C., Castriconi, R., Cantoni, C., Marcenaro, S., Rivera, P., Spaggiari, G. M. et al., PVR (CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis. Mol. Immunol. 2005. 42: 463-469.
27. Carlsten, M., Bjorkstrom, N. K., Norell, H., Bryceson, Y., van Hall, T., Baumann, B. C., Hanson, M. et al., DNAX accessory molecule-1 mediated recognition of freshly isolated ovarian carcinoma by resting natural killer cells. Cancer Res. 2007. 67: 1317-1325.
28. Castriconi, R., Dondero, A., Negri, F., Bellora, F., Nozza, P., Carnemolla, B., Raso, A. et al., Both CD133+ and CD133- medulloblastoma cell lines express ligands for triggering NK receptors and are susceptible to NK-mediated cytotoxicity. Eur. J. Immunol. 2007. 37: 3190-3196.
29. El-Sherbiny, Y. M., Meade, J. L., Holmes, T. D., McGonagle, D., Mackie, S. L., Morgan, A.W., Cook, G. et al., The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells. Cancer Res. 2007. 67: 8444-8449.
30. Reymond, N., Imbert, A. M., Devilard, E., Fabre, S., Chabannon, C., Xerri, L., Farnarier, C. et al., DNAM-1 and PVR regulate monocyte migration through endothelial junctions. J. Exp. Med. 2004. 199: 1331-1341.